维普中文期刊产品整合服务
247篇 您的检索式:作者名="Nusca"
    题名 作者 年代 出处 被引量
1针刺和聚焦冲击波疗法对肩袖肌腱病的止痛作用:一项回顾性临床研究显示文摘Objective:The purpose of the study is to evaluate whether the clinical effects of focused extracorporeal shockwave therapy(f-ESWT)and acupuncture anticipate the clinical response in patients with rotator cuff tendinopathy in the short term.Design:An observational retrospective clinical study.Setting/Location:Physical Medicine and Rehabilitation Unit,Sant’Andrea University Hospital in Rome,Italy.Subjects/Interventions:We analyzed retrospectively thirty patients(22 females and 8 males)with rotator cuff tendinopathy.Fifteen patients underwent f-ESWT and acupuncture combined therapy(Group A)and fifteen patients underwent only f-ESWT therapy(Group B).Outcome measures:The outcome measures were the Visual Analogic Scale(VAS),Assessment Shoulder and Elbow Scale(ASES)and Roles and Maudsley Score(RMS).The follow-ups were T0(pre-treatment),T1(3 weeks after the start of the treatment),and T2(at 8 weeks).In order to compare groups,the ANOVA and Friedman tests were adopted.Group A patients had a more rapid and statistically significant improvement trend in VAS(P<0.001),ASES scale(P<0.001),and a higher level of satisfaction to treatment assessed by RMS(P<0.001)than group B in the short term.Conclusions:The study showed that combined treatment decreases the recovery time of the shoulder involved in terms of pain and motor function in the short term.However,these results shall be confirmed by controlled randomized studies.Enrico Bruno Diana Lalli Riccardo Vallorani Enrica Armienti Maria Chiara Vulpiani Mario Vetrano Donatella Trischitt Sveva Maria Nusca Flavia Santoboni 2020World Journal of Acupuncture-Moxibustion2020,30,3:2
2Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study显示文摘Vincenzo Pasceri Giuseppe Patti Annunziata Nusca Christian Pristipino Giuseppe Richichi Germano Di Sciascio 2004Circulation2004,,6:2
3Statin loading for acute cor-onary syndromes显示文摘NUSCA A MELFI R PATH G 2010Curr Opin Cardiol2010,25,4:1
4Short-term,high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN trial显示文摘Patti G Ricottini E Nusca A 2011Am J Cardiol2011,108,1:1
5Prevention of complications after percu- taneous coronary interventions with statins 显示文摘Mega S Nusca A Patti G 2012Recenti Prog Med2012,103,1:1
6Platelet function and inhibition in ischemic heart disease显示文摘Nusca A Patti G 0,,4:1
7Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Platelet Reactivity Predicts Outcome) study显示文摘Patti G Nusca A Mangiacapra F 2008J Am Coll Cardiol2008,52,14:1
8Statin loading before percutaneous coronary intervention: proposed mechanisms and applications显示文摘Nusca A Melfi R Patti G 2010Future Cardiol2010,6,5:1
9Usefuluness of statin pretreat- mentto prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing precutaneous coronary intervention显示文摘Patti G Nusca A Chello M 2012Am J Cardiol2012,101,09:1
10Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty)study显示文摘Pasceri V Patti G Nusca A 2004Circulation2004,110,6:1
11Statins and their role in pre-percutaneous coronary intervention显示文摘Melfi R Nusca A Patti G 2010Curr Cardiol Rep2010,12,4:1
12Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention显示文摘Patti G Pasceri V Nusca A 2005Ital Heart J Suppl2005,6,9:1
13Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention显示文摘Patti P Nusca A Chello M 0,,:1
14Randenfized trial of atofvastatin for reduction of myocardial damage during conmary intervention:results from the ARMYDA(Atorvaststin for Reduction of Myocardial Damage during Angioplasty)study显示文摘Pascefi V Patti G Nusca A 2004Circulation2004,110,:1
15Usefulness of statin pretreatment to prevent contrast-induced nephmpathy and to improve Xong-term outcome in patients undergoing percutaneous coronary intervention显示文摘Patti G Nusca A Chello M 2008Am J Cardiol2008,101,3:1
16Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percu- taneous coronary intervention (from the ARMYDA- CIN trial 显示文摘Patti G Ricottini E Nusca A 2011Am J Cardiol2011,108,:1
17Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) Study显示文摘Pasceri V Patti G Nusca A 2004Circulation2004,110,6:1
18Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intevention显示文摘PATTI G NUSCA A CHELLO M 2008Am J Cardiol2008,101,3:1
19Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study显示文摘Pasceri V Patti G Nusca A 2004Circulation2004,110,6:1
20Percutaneous coronary interventions and statin therapy 显示文摘Mega S Nusca A Patti G 2012Recenti Prog Med2012,103,1:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费